Major Form of NUP98/HOXC11 Fusion in Adult AML with T(11;12)(p15;q13) Translocation Exhibits Aberrant Trans-Regulatory Activity

B-W Gu,Q Wang,J-M Wang,Y-Q Xue,J Fang,K F Wong,B Chen,Z-Z Shi,J-Y Shi,X-T Bai,D-H Wu,Z Chen,S-J Chen
DOI: https://doi.org/10.1038/sj.leu.2403036
2003-01-01
Leukemia
Abstract:Three adult patients with de novo acute myeloid leukemia of distinct subtypes harboring t(11;12)(p15;q13) have been investigated to characterize the genes involved in that translocation. Through molecular cytogenetics, a chromosome break was detected at the 3′ part of nucleoporin 98 ( NUP98 ) gene at 11p15. Using rapid amplification of cDNA end, we identified the partner gene at 12q13, HOXC11 . Molecular analysis showed that exon 12 of NUP98 was fused in-frame to exon 2 of HOXC11 in all three cases with t(11;12)(p15;q13). Therefore, this type of fusion may represent the major form of the NUP98-HOXC11 chimera so far reported. Moreover, two out of three cases had a confirmed deletion of the 3′ part of NUP98 gene and more telomeric region of 11p harboring a group of tumor-suppressor genes. Interestingly, the NUP98-HOXC11 protein when assayed in a GAL4 reporter system, showed an aberrant trans-regulatory activity as compared to the wild-type HOXC11 in both COS-7 and HL-60 cells. Therefore, NUP98-HOXC11 may contribute to the leukemogenesis by interfering with the cellular mechanism of transcriptional regulation.
What problem does this paper attempt to address?